Diabetic retinopathy: more than meets the eye.

Retinal microvascular dysfunction in diabetes is a major component of diabetic retinopathy. This review highlights recent observations regarding the cellular anatomy that contributes to the blood-retinal barrier and its breakdown, the alterations of macroglial, neuronal, and microglial cells in diabetes, and how these changes lead to loss of vision. In addition, the effects of systemic pathophysiologic influences, including metabolic control, blood pressure, and fluid volume on the formation of diabetic macular edema are discussed. Finally, an overview of inflammatory mechanisms and responses in the retina in diabetes is provided. Together, these new observations provide a broader clinical and research perspective on diabetic retinal vascular dysfunction than previously considered, and provide new avenues for improved treatments to prevent loss of vision.

[1]  M. Cooper,et al.  Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[2]  T. Gardner,et al.  Molecular mechanisms of vascular permeability in diabetic retinopathy. , 1999, Seminars in ophthalmology.

[3]  A. Barber,et al.  Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.

[4]  A. Dick,et al.  IFN-γ and LPS-Mediated IL-10–Dependent Suppression of Retinal Microglial Activation , 2000 .

[5]  J. Jonas,et al.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. , 2001, American journal of ophthalmology.

[6]  K. Miyarnoto.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[7]  E. Chew.  Diabetic retinopathy and lipid abnormalities. , 1997, Current opinion in ophthalmology.

[8]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[9]  M. Riddle,et al.  Early Loss of Blue-Sensitive Color Vision in Patients With Type I Diabetes , 1987, Diabetes Care.

[10]  T. Gardner,et al.  Insulin Rescues Retinal Neurons from Apoptosis by a Phosphatidylinositol 3-Kinase/Akt-mediated Mechanism That Reduces the Activation of Caspase-3* , 2001, The Journal of Biological Chemistry.

[11]  T. Gardner,et al.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. , 2000, Investigative ophthalmology & visual science.

[12]  S. Keinänen-Kiukaanniemi,et al.  The relationship between hemoglobin levels and diabetic retinopathy. , 1997, Journal of clinical epidemiology.

[13]  E. Stefánsson,et al.  Retinal vasoconstriction after laser treatment for diabetic macular edema. , 1993, American journal of ophthalmology.

[14]  T. Gardner,et al.  The molecular structure and function of the inner blood-retinal barrier , 2004, Documenta Ophthalmologica.

[15]  A. Cosgarea,et al.  Renal histamine increases in the streptozotocin-diabetic rat. , 1986, Experimental and molecular pathology.

[16]  A. Garner.  Pathogenesis of Diabetic Retinopathy , 1987 .

[17]  M. Cooper,et al.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. , 1999, Diabetes.

[18]  Philip Raskin,et al.  The treatment of hypertension in adult patients with diabetes. , 2002, Diabetes care.

[19]  H. Chung,et al.  Regulation of retinal and optic nerve blood flow. , 1998, Archives of ophthalmology.

[20]  P. Leuenberger,et al.  Glial reactivity, an early feature of diabetic retinopathy. , 2000, Investigative ophthalmology & visual science.

[21]  V. Parisi,et al.  Visual electrophysiological responses in persons with type 1 diabetes , 2001, Diabetes/metabolism research and reviews.

[22]  I. Romero,et al.  Astrocyte‐endothelial interaction: physiology and pathology , 1992, Neuropathology and applied neurobiology.

[23]  G. Raviola.  The structural basis of the blood-ocular barriers. , 1977, Experimental eye research.

[24]  L. Aiello,et al.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Yannuzzi,et al.  The effects of lipid lowering on diabetic retinopathy. , 1991, American journal of ophthalmology.

[26]  K Miyamoto,et al.  Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. , 2000, Investigative ophthalmology & visual science.

[27]  J. Tarbell,et al.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.

[28]  T. Gardner,et al.  Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1 , 1999, The Journal of Biological Chemistry.

[29]  M Palta,et al.  Predicting progression to severe proliferative diabetic retinopathy. , 1987, Archives of ophthalmology.

[30]  P. Anthony.  Robbins' Pathologic Basis of Disease , 1990 .

[31]  Einar Stefánsson,et al.  Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.

[32]  G. Lundborg,et al.  Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System , 1999, The Journal of Neuroscience.

[33]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[34]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[35]  F. Ferris,et al.  Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. , 1998, Investigative ophthalmology & visual science.

[36]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[37]  T. Gardner,et al.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.

[38]  T. Gardner,et al.  Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons* , 2001, The Journal of Biological Chemistry.

[39]  E. Ling,et al.  Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats , 2000, Visual Neuroscience.

[40]  M. Lorenzi,et al.  Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. , 2001, Diabetes.

[41]  P. Rosenstiel,et al.  Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. , 2002, Investigative ophthalmology & visual science.

[42]  C. Gerhardinger,et al.  Müller cell changes in human diabetic retinopathy. , 1998, Diabetes.

[43]  L. Aiello,et al.  Systemic considerations in the management of diabetic retinopathy. , 2001, American journal of ophthalmology.

[44]  D. Antonetti,et al.  Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. , 2000, Experimental eye research.

[45]  E. Wolpert,et al.  Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin , 2002, Journal of neurochemistry.

[46]  K. Jin,et al.  Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[48]  W. F. V. Eck.  The effect of a low fat diet on the serum lipids in diabetes and its significance in diabetic retinopathy. , 1959 .

[49]  L. Aiello,et al.  Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. , 2000, The Journal of clinical investigation.

[50]  S. Kishi,et al.  Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. , 2001, Journal of diabetes and its complications.

[51]  C E Riva,et al.  Retinal vascular autoregulation in diabetes mellitus. , 1982, Ophthalmology.

[52]  A. Barber,et al.  Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.

[53]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.